HIGHLIGHTS
- who: Huanrong Wang and collaborators from the Harvard Medical School, United States Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China have published the research work: Folate receptor-positive circulating tumor cell count, lymphocyte count and derived neutrophil-to- lymphocyte ratio for diagnosing lung cancer relapse, in the Journal: (JOURNAL)
- what: In this study, the posttreatment hematological indicators of the 68 patients were assessed. The authors demonstrated a significant correlation between CTC levels and T stage. The authors designed a diagnosis-treat-relapse model to investigate the significance of CTCs and other . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.